1-(2-(2-hydroxy-3-(4-phenylpiperidin-1-yl)propoxy)phenyl)-3-phenylpropan-1-one

ID: ALA1963280

PubChem CID: 56643486

Max Phase: Preclinical

Molecular Formula: C29H33NO3

Molecular Weight: 443.59

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(CCc1ccccc1)c1ccccc1OCC(O)CN1CCC(c2ccccc2)CC1

Standard InChI:  InChI=1S/C29H33NO3/c31-26(21-30-19-17-25(18-20-30)24-11-5-2-6-12-24)22-33-29-14-8-7-13-27(29)28(32)16-15-23-9-3-1-4-10-23/h1-14,25-26,31H,15-22H2

Standard InChI Key:  ZHUPKALTWVLYNU-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 33 36  0  0  0  0  0  0  0  0999 V2000
   -5.9598   -6.5791    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9609   -7.4065    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2461   -7.8194    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5297   -7.4060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5325   -6.5755    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2479   -6.1664    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8196   -6.1603    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1036   -6.5701    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8227   -5.3353    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3907   -6.1549    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6747   -6.5647    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6747   -7.3886    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9595   -7.7983    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2456   -7.3831    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2514   -6.5538    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9671   -6.1478    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8145   -7.8174    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8133   -8.6424    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0981   -9.0538    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0968   -9.8788    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3843   -8.6402    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3817  -10.2902    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3842  -11.1132    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6732  -11.5245    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9569  -11.1144    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9562  -10.2884    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6718   -9.8726    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2473  -11.5250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2504  -12.3511    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4623  -12.7651    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1787  -12.3541    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1778  -11.5248    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4645  -11.1146    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
 16 11  1  0
  7  8  1  0
  4 17  1  0
 17 18  1  0
  7  9  2  0
 18 19  1  0
  4  5  1  0
 19 20  1  0
  8 10  1  0
 19 21  1  0
  2  3  1  0
 20 22  1  0
 22 23  1  0
 10 11  1  0
  5  6  2  0
 11 12  2  0
  6  1  1  0
 12 13  1  0
 22 27  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
  1  2  2  0
 13 14  2  0
 28 29  2  0
  5  7  1  0
 29 30  1  0
 14 15  1  0
 30 31  2  0
  3  4  2  0
 31 32  1  0
 15 16  2  0
 32 33  2  0
 33 28  1  0
 25 28  1  0
M  END

Associated Targets(Human)

KCNH2 Tclin HERG (29587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SCN5A Tclin Sodium channel protein type V alpha subunit (3462 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KCNJ11 Tclin Potassium channel, inwardly rectifying, subfamily J, member 11 (112 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2D6 Tclin Cytochrome P450 2D6 (33882 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Liver microsomes (16955 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HEK293 (82097 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HepG2 (196354 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Raji (5516 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BJ (6930 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Plasmodium falciparum (966862 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Liver (8163 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasmodium berghei (192651 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 443.59Molecular Weight (Monoisotopic): 443.2460AlogP: 5.12#Rotatable Bonds: 10
Polar Surface Area: 49.77Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 7.98CX LogP: 5.31CX LogD: 4.63
Aromatic Rings: 3Heavy Atoms: 33QED Weighted: 0.44Np Likeness Score: -0.59

References

1. Lowes D, Pradhan A, Iyer LV, Parman T, Gow J, Zhu F, Furimsky A, Lemoff A, Guiguemde WA, Sigal M, Clark JA, Wilson E, Tang L, Connelly MC, Derisi JL, Kyle DE, Mirsalis J, Guy RK..  (2012)  Lead optimization of antimalarial propafenone analogues.,  55  (13): [PMID:22708838] [10.1021/jm300286a]

Source